Media Inquiries

If you are interested in interviewing a CCR scientist, OR you are a scientist who has been contacted by a member of the media, please contact the NCI Press Office at ncipressofficers@mail.nih.gov or by phone at 240.760.6600.

News and Events

engineered natural killer cells (yellow) can expand in solid tumors and kill tumor cells (red)

Stem cell–derived natural killer cells engineered to attack solid tumors

Cancer-killing natural killer cells could pave the way to off-the-shelf immunotherapy for solid tumors.

Clinical trial researches therapy for squamous cell carcinomas

Vassiliki Saloura, M.D., Ph.D., Stadtman Investigator in the Thoracic and GI Malignancies Branch, is leading CCR participation in a trial to research photoimmunotherapy with imaging for adults with head and neck or cutaneous squamous cell carcinoma.

New CAR T-cell therapy eliminates rhabdomyosarcoma in mice

After seeing excellent results of a CAR T-cell therapy against rhabdomyosarcoma in mice, a team of CCR researchers is preparing to test the immunotherapy in humans.

CCR Hosts “Frontiers in Basic Immunology” Symposium

CCR hosted a two-day international symposium, titled “Frontiers in Basic Immunology,” sponsored by the NCI Center of Excellence in Immunology (CEI). The program included a lineup of presentations from NCI and worldwide academic university speakers and a lively poster session.

Clinical trial researches radiation therapy for prostate tumors

A clinical trial led by Krishnan R. Patel, M.D., Assistant Research Physician in the Radiation Oncology Branch, is researching radiation therapy for prostate cancer.

The ups and downs of a rare blood cancer won’t stop one resilient patient

Even with a rare cancer diagnosis and a roller-coaster ride of a journey, Luis Miguel Cruz continues to find the motivation to keep moving forward through every setback. Along the way, he has inspired and brought joy to those he has met, both in person and digitally.